Omeros | OMER - Crediti Commerciali





Crediti Commerciali Cambiamento Data
Adma Biologics USD 135.86M 22.57M 2026-03
Alnylam Pharmaceuticals USD 912.74M 28.78M 2026-06
BioMarin Pharmaceutical USD 1.06B 157.13M 2026-06
Cytokinetics USD 6.83M 10.94M 2026-03
Gilead Sciences USD 5.06B 314M 2026-06
Heron Therapeutics USD 89.59M 8.54M 2025-12
Immunic USD 333K 156K 2025-12
Insmed USD 215.32M 36.77M 2026-06
Knight Therapeutics CAD 183M 7.46M 2025-12
MacroGenics USD 10.42M 2.95M 2026-03
Omeros USD 8.08M 440K 2024-06
Pacira USD 132.42M 6.78M 2026-06
Pfizer USD 16.19B 19M 2026-06
Rockwell Medical USD 10.84M 250K 2024-06
Sangamo BioSciences USD 581K 110K 2024-06
Sarepta Therapeutics USD 393.8M 154.11M 2026-06
United Therapeutics USD 310.3M 1.7M 2026-06
Vertex Pharmaceuticals USD 2.13B 138.2M 2026-06